Liposomes for (trans)dermal drug delivery: The skin-PVPA as a novel in vitro stratum corneum model in formulation development

Journal of Liposome Research

Volumn 24, Issue 4, 2014, Pages 313-322

  Palac, Zora ^a   Engesland, André ^b   Flaten, Gøril Eide ^b   Škalko Basnet, Nataša ^b   Filipović Grčić, Jelena ^a   Vanić, Željka ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Nanotechnology; Permeability; Phospholipids; Skin; Sustained release

Indexed keywords

DICLOFENAC; LIPOSOME; PHOSPHOLIPID; PROPYLENE GLYCOL; SURFACTANT; DELAYED RELEASE FORMULATION; DERMATOLOGICAL AGENT; DRUG CARRIER;

ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; DRUG SCREENING; DRUG STABILITY; ELASTICITY; EXPERIMENTAL MODEL; HYDROPHILICITY; IN VITRO STUDY; PARTICLE SIZE; PHOSPHOLIPID VESICLE; PHOSPHOLIPID VESICLE PERMEATION ASSAY; PHYSICAL CHEMISTRY; STRATUM CORNEUM; SURFACE CHARGE; SUSTAINED DRUG RELEASE; TRANSDERMAL DRUG ADMINISTRATION; ADMINISTRATION AND DOSAGE; CHEMICAL MODEL; CHEMISTRY; COMPARATIVE STUDY; DELAYED RELEASE FORMULATION; INTRADERMAL DRUG ADMINISTRATION; PERMEABILITY; SOLUBILITY;

ADMINISTRATION, CUTANEOUS; DELAYED-ACTION PREPARATIONS; DERMATOLOGIC AGENTS; DRUG CARRIERS; DRUG COMPOUNDING; LIPOSOMES; MODELS, CHEMICAL; PERMEABILITY; PHOSPHOLIPIDS; PROPYLENE GLYCOL; SOLUBILITY; SURFACE-ACTIVE AGENTS;

EID: 84911491772     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.3109/08982104.2014.899368     Document Type: Article

References (47)

1. Barry BW. (2001). Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci 14:101-14.
2. Bartlett GR. (1959). Phosphorus assay in column chromatography. J Biol Chem 234:466-8.
3. Cadena PG, Pereira MA, Cordeiro RB, et al. (2013). Nanoencapsulation of quercetin and resveratrol into elastic liposomes. Biochim Biophys Acta 1828:309-16.
4. Cereda CM, Franz-Montan M, da Silva CM, et al. (2013). Transdermal delivery of butamben using elastic and conventional liposomes. J Liposome Res 23:228-34.
5. Cevc G, Blume G. (1992). Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim Biophys Acta 1104:226-32.
6. Cevc G, Gebauer D, Stieber J, et al. (1998). Ultraflexible vesicles, transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin. Biochim Biophys Acta 1368:201-15.
7. Cevc G, Schatzlein A, Richardsen H. (2002). Ultradeformable lipid vesicles can penetrate the skin and other semi-permeable barriers unfragmented. Evidence from double label CLSM experiments and direct size measurements. Biochim Biophys Acta 1564:21-30.
8. Cevc G, Vierl U. (2010). Nanotechnology and the transdermal route: a state of the art review and critical appraisal. J Control Release 141:277-99.
9. Chen Y, Lu Y, Chen J, et al. (2009). Enhanced bioavailability of the poorly water-soluble drug fenofibrate by using liposomes containing a bile salt. Int J Pharm 376:153-60.
10. Chilcott RP, Barai N, Beezer AE, et al. (2005). Inter- and intralaboratory variation of in vitro diffusion cell measurements: an international multicenter study using quasi-standardized methods and materials. J Pharm Sci 94:632-8.
11. Delgado-Charro MB, Guy RH. (2001). Transdermal drug delivery. In: Hillery AM, Lloyd AW, Swarbrick J, eds. Drug delivery and targeting for pharmacists and pharmaceutical scientists. London-New York: Taylor & Francis, 208-36.
12. Dragicevic-Curic N, Scheglmann D, Albrecht V, Fahr A. (2008). Temoporfin-loaded invasomes: development, characterization and in vitro skin penetration studies. J Control Release 127:59-69.
13. El Maghraby GM, Williams AC, Barry BW. (2006). Can drug-bearing liposomes penetrate intact skin? J Pharm Pharmacol 58:415-29.
14. El Zaafarany GM, Awad GA, Holayel SM, Mortada ND. (2010). Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery. Int J Pharm 397:164-72.
15. Elmoslemany RM, Abdallah OY, El-Khordagui LK, Khalafallah NM. (2012). Propylene glycol liposomes as a topical delivery system for miconazole nitrate: comparison with conventional liposomes. AAPS PharmSciTech 13:723-31.
16. Elsayed MMA, Abdallah OY, Naggar VF, Khalafallah NM. (2007a). PG-liposomes: novel lipid vesicles for skin delivery of drugs. J Pharm Pharmacol 59:1447-50.
17. Elsayed MMA, Abdallah OY, Naggar VF, Khalafallah NM. (2007b). Lipid vesicles for skin delivery of drugs: reviewing three decades of research. Int J Pharm 332:1-16.
18. Engesland A, Skar M, Hansen T, et al. (2013). New applications of phospholipid vesicle-based permeation assay: permeation model mimicking skin barrier. J Pharm Sci 102:1588-600.
19. Ferderber K, Hook S, Rades T. (2009). Phosphatidyl choline-based colloidal systems for dermal and transdermal drug delivery. J Liposome Res 19:267-77.
20. Flaten GE, Bunjes H, Luthman K, Brandl M. (2006a). Drug permeability across a phospholipid vesicle-based barrier 2. Characterization of barrier structure, storage stability and stability towards pH changes. Eur J Pharm Sci 28:336-43.
21. Flaten GE, Dhanikula AB, Luthman K, Brandl M. (2006b). Drug permeability across a phospholipid vesicle based barrier: a novel approach for studying passive diffusion. Eur J Pharm Sci 27:80-90.
22. Flaten GE, Skar M, Luthman K, Brandl M. (2007). Drug permeability across a phospholipid vesicle based barrier: characterization of drug-membrane interactions and the effect of agitation on the barrier integrity and on the permeability. Eur J Pharm Sci 30:324-32.
23. Ghanbarzadeh S, Arami S. (2013). Enhanced transdermal delivery of diclofenac sodium via conventional liposomes, ethosomes, and transferosomes. BioMed Res Int 2013:1-7.
24. Gillet A, Compere P, Lecomte F, et al. (2011a). Liposome surface charge influence on skin penetration behavior. Int J Pharm 411:223-31.
25. Gillet A, Lecomte F, Hubert P, et al. (2011b). Skin penetration behaviour of liposomes as a function of their composition. Eur J Pharm Biopharm 79:43-53.
26. Herkenne C, Naik A, Kalia YN, et al. (2007). Ibuprofen transport into and through skin from topical formulations: in vitro-in vivo comparison. J Invest Dermatol 127:135-42.
27. Honeywell-Nguyen PL, Bouwstra JA. (2005). Vesicles as a tool for tansdermal and dermal delivery. Drug Discov Today Technol 2:67-74.
28. Hurler J, Berg OA, Skar M, et al. (2012). Improved burns therapy: liposomes-in-hydrogel delivery system for mupirocin. J Pharm Sci 101:3906-15.
29. Jain S, Jain P, Umamaheshwari RB, Jain NK. (2003). Transfersomes - a novel vesicular carrier for enhanced transdermal delivery: development, characterization, and performance evaluation. Drug Dev Ind Pharm 29:1013-26.
30. Kanzer J, Tho I, Flaten GE, et al. (2010). In-vitro permeability screening of melt-estrudate formulations containing poorly water-soluble drug compounds using the phospholipid vesicle-based barrier. J Pharm Pharmacol 62:1591-8.
31. Kawano K, Onose E, Hattori Y, Maitani Y. (2009). Higher liposomal membrane fluidity enhances the in vitro antitumor activity of folate-targeted liposomal mitoxantrone. Mol Pharm 6:98-104.
32. Kikuchi H, Yamauchi H, Hirota S. (1994). A polyol dilution method for mass production of liposomes. J Liposome Res 4:71-91.
33. Lane ME. (2013). Skin penetration enhancers. Int J Pharm 447:12-21.
34. Manconi M, Mura S, Sinico C, et al. (2009). Development and characterization of liposomes containing glycols as carriers for diclofenac. Colloid Surface A 342:53-8.
35. Oliveira G, Beezer AE, Hadgraft J, Lane ME. (2010). Alcohol enhanced permeation in model membranes. Part I. Thermodynamic and kinetic analyses of membrane permeation. Int J Pharm 393:61-7.
36. Pavelić Ž, Škalko-Basnet N, Filipović-Grčić J, et al. (2005). Development and in vitro evaluation of a liposomal vaginal delivery system for acyclovir. J Control Release 106:34-43.
37. Prow TW, Grice JE, Lin LL, et al. (2011). Nanoparticles and microparticles for skin drug delivery. Adv Drug Deliv Rev 63:470-91.
38. Salerno C, Carlucci AM, Bregni C. (2010). Study of in vitro drug release and percutaneous absorption of fluconazole from topical dosage forms. AAPS Pharm Sci Tech 11:986-93.
39. Sinko B, Garrigues TM, Balogh GT, et al. (2012). Skin-PAMPA: a new method for fast prediction of skin penetration. Eur J Pharm Sci 45:698-707.
40. Subongkot T, Duangjit S, Rojanarata T, et al. (2012). Ultradeformable liposomes with terpenes for delivery of hydrophilic compound. J Liposome Res 22:254-62.
41. Šentjurc M, Vrhovnik K, Kristl J. (1999). Liposomes as a topical delivery system: the role of size on transport studied by the EPR imaging method. J Control Release 59:87-97.
42. Touitou E, Dayan N, Bergelson L, et al. (2000). Ethosomes - novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release 65:403-18.
43. Vanić Ž, Barnert S, Süss R, Schubert R. (2012). Fusogenic activity of PEGylated pH-sensitive liposomes. J Liposome Res 22:148-57.
44. Vanić Ž, Hafner A, Bego M, Škalko-Basnet N. (2013). The characterization of various deformable liposomes with metronidazole. Drug Dev Ind Pharm 39:481-8.
45. Vanić Ž, Hurler J, Ferderber K, et al. (2014). Novel vaginal drug delivery system: deformable propylene glycol liposomes-in-hydrogel. J Liposome Res 24:27-36.
46. Verma DD, Verma S, Blume G, Fahr A. (2003). Particle size of liposomes influences dermal delivery of substances into skin. Int J Pharm 258:141-51.
47. Zhao YZ, Dai DD, Lu CT, et al. (2013). Epirubicin loaded with propylene glycol liposomes significantly overcomes multidrug resistance in breast cancer. Cancer Lett 330:74-83.